The authors reported an analysis on one year of data from the first cohort of 15 patients from a single trial site that received subcutaneous implantation of cell products combined with an immunosuppressive regimen.
[Cell Stem Cell]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
169601
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
